BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36509645)

  • 21. Clinical features and long-term outcomes of patients with type 2 autoimmune pancreatitis.
    de Pretis N; Carlin M; Calderini E; Caldart F; Conti Bellocchi MC; Amodio A; De Marchi G; Campagnola P; Crinò SF; Bernardoni L; Gabbrielli A; Martinelli L; Frulloni L
    United European Gastroenterol J; 2024 Apr; 12(3):319-325. PubMed ID: 38217278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosing autoimmune pancreatitis with the Unifying-Autoimmune-Pancreatitis-Criteria.
    Schneider A; Michaely H; Rückert F; Weiss C; Ströbel P; Belle S; Hirth M; Wilhelm TJ; Haas SL; Jesenofsky R; Schönberg S; Marx A; Singer MV; Ebert MP; Pfützer RH; Löhr JM
    Pancreatology; 2017; 17(3):381-394. PubMed ID: 28365128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DWI of Autoimmune Pancreatitis: Is It an Imaging Biomarker for Disease Activity?
    Zhu L; Zhang W; Jin Z; Sun Z; Xue H; Denecke T; Hamm B; Lv H; Zhang S; Lai Y
    AJR Am J Roentgenol; 2021 May; 216(5):1240-1246. PubMed ID: 33760653
    [No Abstract]   [Full Text] [Related]  

  • 24. Autoimmune Pancreatitis and IgG4-Related Disease: The Storiform Discovery to Treatment.
    Okazaki K
    Dig Dis Sci; 2019 Sep; 64(9):2385-2394. PubMed ID: 31363956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis, treatment and long-term outcomes of autoimmune pancreatitis in Spain based on the International Consensus Diagnostic Criteria: A multi-centre study.
    López-Serrano A; Crespo J; Pascual I; Salord S; Bolado F; Del-Pozo-García AJ; Ilzarbe L; de-Madaria E; Moreno-Osset E;
    Pancreatology; 2016; 16(3):382-90. PubMed ID: 26944001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steroid Therapy and Steroid Response in Autoimmune Pancreatitis.
    Matsubayashi H; Ishiwatari H; Imai K; Kishida Y; Ito S; Hotta K; Yabuuchi Y; Yoshida M; Kakushima N; Takizawa K; Kawata N; Ono H
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and pathological differences between serum immunoglobulin G4-positive and -negative type 1 autoimmune pancreatitis.
    Paik WH; Ryu JK; Park JM; Song BJ; Park JK; Kim YT; Lee K
    World J Gastroenterol; 2013 Jul; 19(25):4031-8. PubMed ID: 23840149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early pancreatic volume reduction on CT predicts relapse in patients with type 1 autoimmune pancreatitis treated with steroids.
    Ohno Y; Kumagi T; Yokota T; Azemoto N; Tanaka Y; Tange K; Inada N; Miyata H; Imamura Y; Koizumi M; Kuroda T; Hiasa Y;
    Orphanet J Rare Dis; 2016 Jul; 11(1):103. PubMed ID: 27465035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and classification of autoimmune pancreatitis.
    Okazaki K; Tomiyama T; Mitsuyama T; Sumimoto K; Uchida K
    Autoimmun Rev; 2014; 13(4-5):451-8. PubMed ID: 24424184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis.
    Kubota K; Iida H; Fujisawa T; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Saito S; Ohshiro H; Kakuta Y; Nakajima A
    Gastrointest Endosc; 2007 Dec; 66(6):1142-51. PubMed ID: 18061714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic strategy for autoimmune pancreatitis.
    Kamisawa T; Satake K
    Adv Med Sci; 2008; 53(2):145-8. PubMed ID: 18762470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment.
    Overbeek KA; Poulsen JL; Lanzillotta M; Vinge-Holmquist O; Macinga P; Demirci AF; Sindhunata DP; Backhus J; Algül H; Buijs J; Levy P; Kiriukova M; Goni E; Hollenbach M; Miksch RC; Kunovsky L; Vujasinovic M; Nikolic S; Dickerson L; Hirth M; Neurath MF; Zumblick M; Vila J; Jalal M; Beyer G; Frost F; Carrara S; Kala Z; Jabandziev P; Sisman G; Akyuz F; Capurso G; Falconi M; Arlt A; Vleggaar FP; Barresi L; Greenhalf B; Czakó L; Hegyi P; Hopper A; Nayar MK; Gress TM; Vitali F; Schneider A; Halloran CM; Trna J; Okhlobystin AV; Dagna L; Cahen DL; Bordin D; Rebours V; Mayerle J; Kahraman A; Rasch S; Culver E; Kleger A; Martínez-Moneo E; Røkke O; Hucl T; Olesen SS; Bruno MJ; Della-Torre E; Beuers U; Löhr JM; Rosendahl J;
    Clin Gastroenterol Hepatol; 2024 May; 22(5):994-1004.e10. PubMed ID: 38184096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical course of type 1 autoimmune pancreatitis patients without steroid treatment: a Japanese multicenter study of 97 patients.
    Kubota K; Kamisawa T; Hirano K; Hirooka Y; Uchida K; Ikeura T; Shiomi H; Ohara H; Shimizu K; Arakura N; Kanno A; Sakagami J; Itoi T; Ito T; Ueki T; Nishino T; Inui K; Mizuno N; Yoshida H; Sugiyama M; Iwasaki E; Irisawa A; Okazaki K; Kawa S; Shimosegawa T; Takeyama Y; Chiba T
    J Hepatobiliary Pancreat Sci; 2018 Apr; 25(4):223-230. PubMed ID: 29430861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent enlargement of the pancreatic gland after glucocorticoid therapy increases the risk of relapse in IgG4-related autoimmune pancreatitis.
    Lu H; Peng L; Zhu L; Feng R; Zhou J; Liu Z; Li J; Luo X; Peng Y; Qin C; Fei Y; Zhao Y; Zeng X; Lai Y; Zhang W
    Clin Rheumatol; 2022 Jun; 41(6):1709-1718. PubMed ID: 35175447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis.
    Park DH; Kim MH; Oh HB; Kwon OJ; Choi YJ; Lee SS; Lee TY; Seo DW; Lee SK
    Gastroenterology; 2008 Feb; 134(2):440-6. PubMed ID: 18155707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. International consensus for the treatment of autoimmune pancreatitis.
    Okazaki K; Chari ST; Frulloni L; Lerch MM; Kamisawa T; Kawa S; Kim MH; Lévy P; Masamune A; Webster G; Shimosegawa T
    Pancreatology; 2017; 17(1):1-6. PubMed ID: 28027896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis of type 1 autoimmune pancreatitis after corticosteroid therapy-induced remission in terms of relapse and diabetes mellitus.
    Miyazawa M; Takatori H; Shimakami T; Kawaguchi K; Kitamura K; Arai K; Matsuda K; Sanada T; Urabe T; Inamura K; Kagaya T; Mizuno H; Fuchizaki U; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
    PLoS One; 2017; 12(11):e0188549. PubMed ID: 29166415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in autoimmune pancreatitis: type 1 and type 2.
    Kamisawa T; Chari ST; Lerch MM; Kim MH; Gress TM; Shimosegawa T
    Gut; 2013 Sep; 62(9):1373-80. PubMed ID: 23749606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of autoimmune pancreatitis.
    Matsubayashi H; Kakushima N; Takizawa K; Tanaka M; Imai K; Hotta K; Ono H
    World J Gastroenterol; 2014 Nov; 20(44):16559-69. PubMed ID: 25469024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicentric Italian survey on daily practice for autoimmune pancreatitis: Clinical data, diagnosis, treatment, and evolution toward pancreatic insufficiency.
    Barresi L; Tacelli M; Crinò SF; Attili F; Petrone MC; De Nucci G; Carrara S; Manfredi G; Capurso G; De Angelis CG; Crocellà L; Fantin A; Dore MF; Garribba AT; Tarantino I; De Pretis N; Pagliari D; Rossi G; Manes G; Preatoni P; Barbuscio I; Tuzzolino F; Traina M; Frulloni L; Costamagna G; Arcidiacono PG; Buscarini E; Pezzilli R;
    United European Gastroenterol J; 2020 Jul; 8(6):705-715. PubMed ID: 32397913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.